Hong Kong stocks witnessed narrower gains, as the Hang Seng Index inched up 0.6% and the Hang Seng TECH Index advanced 0.7%. In contrast, the pharmaceutical sector underperformed, with notable declines: CSPC Pharmaceutical Group slipped nearly 5%, WuXi Biologics retreated over 4%, and Sino Biopharmaceutical fell by more than 3%.
